Back to search

Clemson University

Killer cell activation by a novel multifunctional protein: an immuno/gene therapy for cancer

Abstract

dc:description.abstract

One of the characteristics of advanced tumors is the evasion of the immune system. There are multiple methods that tumor cells employ to achieve this including reducing the expression of activating ligands on the cell surface and a shift in the tumor microenvironment toward pro-tumor cytokines. The purpose of this research is to develop a novel bifunctional fusion protein that will target these two deficiencies in the tumor microenvironment and activate killer cells that are already present. The proposed protein combines the extracellular domain of a ligand for the killer cell activating receptor NKG2D and Interleukin-12 (IL-12). It is hypothesized that when expressed by tumor cells by gene therapy, the protein will simultaneously activate NK and other killer cells using the NKG2D receptor, and deliver a locally high dose of IL-12 to the tumor microenvironment where it can interact with the IL-12 receptor and enhance cytotoxicity.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (PhD)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Biological Sciences

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Tietje, Ashlee
Contributors dc:contributor
  • Yanzhang Wei
  • Lisa Bain
  • Charles Rice
  • Xianzhong Yu

Subjects

dc:subject × 8

Identifiers

dc:identifier.*
Repository record dc:identifier
https://open.clemson.edu/all_dissertations/1520

Chain of custody

source
Harvested from
Clemson University
Base URL
open.clemson.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Tietje, Ashlee. Killer cell activation by a novel multifunctional protein: an immuno/gene therapy for cancer. Dissertation thesis, https://open.clemson.edu/all_dissertations/1520